Lupin Subsidiary Acquires 9 Brands in South Africa
By Rediff Money Desk, New Delhi Oct 04, 2024 19:09
Lupin's subsidiary, Pharma Dynamics, acquires 9 brands from MNI in South Africa, expanding its footprint in complementary and alternative medicines.
New Delhi, Oct 4 (PTI) Drug firm Lupin on Friday said its subsidiary has acquired nine brands from the Medical Nutritional Institute SA (MNI) in South Africa, through a partnership deal with ImpiloVest.
Pharma Dynamics has acquired the nine brands along with their associated trademarks through a partnership deal with ImpiloVest, a South African investment firm, Lupin said in a statement.
The acquired brands include AntaGolin, RyChol, NeuroVance, SkinVance, FlamLeve, Rheumalin, SleepVance, ImmunoVance, and OviVance, it added.
These products cater to a range of health issues such as metabolic syndrome, insulin resistance, cognitive function, skin health, inflammation, joint care, sleep quality, immune support, and women's hormonal well-being.
"This acquisition is a major step for Lupin to expand our footprint in the complementary and alternative medicines sector," Lupin President EMEA Thierry Volle said.
MNI's innovative plant-based products align perfectly with company's goal to provide holistic and sustainable healthcare solutions to patients in South Africa, he added. Lupin shares on Friday ended 0.65 per cent up at Rs 2,197.60 apiece on the BSE.
Pharma Dynamics has acquired the nine brands along with their associated trademarks through a partnership deal with ImpiloVest, a South African investment firm, Lupin said in a statement.
The acquired brands include AntaGolin, RyChol, NeuroVance, SkinVance, FlamLeve, Rheumalin, SleepVance, ImmunoVance, and OviVance, it added.
These products cater to a range of health issues such as metabolic syndrome, insulin resistance, cognitive function, skin health, inflammation, joint care, sleep quality, immune support, and women's hormonal well-being.
"This acquisition is a major step for Lupin to expand our footprint in the complementary and alternative medicines sector," Lupin President EMEA Thierry Volle said.
MNI's innovative plant-based products align perfectly with company's goal to provide holistic and sustainable healthcare solutions to patients in South Africa, he added. Lupin shares on Friday ended 0.65 per cent up at Rs 2,197.60 apiece on the BSE.
Source: PTI
DISCLAIMER - This article is from a syndicated feed. The original source is responsible for accuracy, views & content ownership. Views expressed may not reflect those of rediff.com India Limited.
You May Like To Read
TODAY'S MOST TRADED COMPANIES
- Company Name
- Price
- Volume
- Vodafone Idea L
- 9.80 ( -0.71)
- 44492337
- G V Films
- 0.94 (+ 9.30)
- 37404318
- Jaiprakash Power Ven
- 19.44 ( -3.38)
- 30530141
- Spicejet Ltd.
- 62.79 ( -4.25)
- 22824171
- Srestha Finvest
- 0.89 (+ 4.71)
- 21696619
MORE NEWS
Ujjivan Small Finance Bank Gets RBI Approval...
Ujjivan Small Finance Bank receives RBI approval for foreign exchange services,...
Deepfakes & Phishing: Scammers Target Users...
Scammers are creating deepfake videos of celebrities like Mukesh Ambani and Virat Kohli...
Paytm Appoints Deependra Singh Rathore as CTO
Paytm owner One 97 Communications Limited (OCL) has appointed Deependra Singh Rathore...